Prostatic inflammation detected in initial biopsy specimens and urinary Pyuria are predictors of negative repeat prostate biopsy

Journal of Urology

Volumn 185, Issue 5, 2011, Pages 1722-1727

  Fujita, Kazutoshi ^a,b   Hosomi, Masahiro ^a   Tanigawa, Go ^a   Okumi, Masayoshi ^a   Fushimi, Hiroaki ^a   Yamaguchi, Seiji ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b NONE   (Japan)

Author keywords

biopsy; inflammation; neutrophils; prostate; prostate specific antigen

Indexed keywords

C REACTIVE PROTEIN; PROSTATE SPECIFIC ANTIGEN;

AGE; AGED; ARTICLE; CONTROLLED STUDY; DENSITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; JAPANESE; LEUKOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; MONONUCLEAR CELL; NEUTROPHIL; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE VOLUME; PYURIA; URINALYSIS; VELOCITY;

AGED; BIOPSY; HUMANS; INFLAMMATION; JAPAN; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PYURIA; RETREATMENT; RISK FACTORS; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79953784966     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.058     Document Type: Article

References (22)

1. R.B. Nadler, P.A. Humphrey, and D.S. Smith Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels J Urol 154 1995 407
2. C.G. Roehrborn, P. Boyle, and A.L. Gould Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 1999 581
3. O. Yaman, C. Gogus, and O. Tulunay Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation Urol Int 71 2003 160
4. P.H. Schatteman, L. Hoekx, and J.J. Wyndaele Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density Eur Urol 37 2000 404
5. E. Kandirali, C. Boran, and E. Serin Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients Urology 70 2007 743
6. R.K. Nam, R. Saskin, and Y. Lee Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 183 2010 963
7. K. Fujita, P. Landis, and B.K. McNeil Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance J Urol 182 2009 2664
8. P.H. Gann, A. Fought, and R. Deaton Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach J Clin Oncol 28 2010 1714
9. R.J. Cohen, B.A. Shannon, and J.E. McNeal Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? J Urol 173 2005 1969
10. I. Stancik, W. Luftenegger, and M. Klimpfinger Effect of NIH-IV prostatitis on free and free-to-total PSA Eur Urol 46 2004 760
11. K. Okada, M. Kojima, and Y. Naya Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer Urology 55 2000 892
12. J.C. Nickel, L.D. True, and J.N. Krieger Consensus development of a histopathological classification system for chronic prostatic inflammation BJU Int 87 2001 797
13. B. Djavan, Y.K. Fong, and V. Ravery Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A multi-institutional prospective European study Eur Urol 47 2005 38
14. D.W. Keetch, J.M. McMurtry, and D.S. Smith Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies J Urol 156 1996 428
15. P.G. Borboroglu, S.W. Comer, and R.H. Riffenburgh Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies J Urol 163 2000 158
16. T. Kato, H. Suzuki, and A. Komiya Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer Int J Urol 13 2006 915
17. C.H. Muller, R.E. Berger, and L.E. Mohr Comparison of microscopic methods for detecting inflammation in expressed prostatic secretions J Urol 166 2001 2518
18. T. Terakawa, H. Miyake, and N. Kanomata Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL Urology 72 2008 1194
19. H. Singh, E.I. Canto, and S.F. Shariat Predictors of prostate cancer after initial negative systematic 12 core biopsy J Urol 171 2004 1850
20. C.A. Mochtar, L.A. Kiemeney, and M.M. van Riemsdijk Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia Eur Urol 44 2003 695
21. S.M. Aubin, J. Reid, and M.J. Sarno PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial J Urol 184 2010 1947
22. K. Okada, K. Okihara, and K. Kitamura Community-based prostate cancer screening in Japan: predicting factors for positive repeat biopsy Int J Urol 17 2010 541